[Clinical experiments in treatment of obesity with preludin (2-phenyl-3-methyl-1, 4-tetraphydrooxazine].
D009765:Obesity / Q000628:therapy*; D010633:Phenmetrazine; D013566:Sympathomimetics / Q000627:therapeutic use*
D013566:Sympathomimetics; D010633:Phenmetrazine
OBESITY/therapy; SYMPATHOMIMETICS/therapeutic use
Doświadczenia kliniczne w leczeniu otyłoci preludyna (2-fenylo-3-metylo-tetrahydro-1, 4-oksazyna.